Skip to content
OpenCapital
Get started

Amphastar Pharmaceuticals AMPH Current Portion of Long-Term Debt and Finance Lease Obligations

Current Portion of Long-Term Debt and Finance Lease Obligations at other companies

Cardinal Health logo
Cardinal HealthCAH
$671M+23.6%
AptarGroup logo
AptarGroupATR
——
AbbVie logo
AbbVieABBV
——
Baxter International logo
Baxter InternationalBAX
——

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M—
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$927.72M-19.9%
Enterprise value$1.44B-11.3%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%—
Debt / equity0.2×—
Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's current portion of long-term debt and finance lease obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's current portion of long-term debt and finance lease obligations?
Amphastar Pharmaceuticals (AMPH) reported current portion of long-term debt and finance lease obligations of $1.67M in Q1 2026.
How has Amphastar Pharmaceuticals's current portion of long-term debt and finance lease obligations changed year-over-year?
Amphastar Pharmaceuticals's current portion of long-term debt and finance lease obligations increased by 646.0% year-over-year, from $224K to $1.67M.
What is the long-term trend for Amphastar Pharmaceuticals's current portion of long-term debt and finance lease obligations?
Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's current portion of long-term debt and finance lease obligations has grown at a -33.1% compound annual growth rate (CAGR), from $12.26M to $1.64M.